Rohini R. Datta

Ms. Rohini R. Datta

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
RDRohini R. Datta
Rohini R. Datta
BPBojana Petrovic
Bojana Petrovic
ATArgerie Tsimicalis
Argerie Tsimicalis
AHA. Fuchsia Howard
A. Fuchsia Howard
EDEmily K. Drake
Emily K. Drake
Jacqueline BenderJacqueline Bender
Jacqueline Bender
A cancer diagnosis disrupts the social networks of adolescents and young adults (AYAs), impacting their overall health and wellbeing. This cross-sectional study examined the social network integration (SNI; size and frequency of contact) of AYAs with cancer in Canada. A survey was distributed to AYAs with cancer at an urban cancer centre and across Canada (n = 334). SNI was measured with the Berkman–Syme Social Network Index (SNI) and a modified version accounting for online interactions (SNI+). A multivariable logistic regression analysis was performed to identify factors associated with SNI and SNI+. A total of 54.8% and 68% of AYAs with cancer were classified as socially integrated with each measure, respectively. Living with others was associated with greater SNI and SNI+ (SNI OR = 3.27, 95% CI = 1.39, 7.72; SNI+ OR = 2.52, 95% CI = 1.14, 5.58), and an annual personal income of >CAD 80,000 was associated with greater SNI+ (SNI+ OR = 2.92, 95% CI = 1.09, 7.77). A significant proportion of AYAs with cancer are socially isolated. AYAs with cancer who live alone and whose personal income is less than CAD 80,000 are at a higher risk of social isolation. Digital technology could be leveraged to increase the SNI of AYAs with cancer.

15 January 2026 in Cambridge Prisms: Global Mental Health
Verified
Journal Article
Open access
PDF file
RDRohini R. Datta
Rohini R. Datta
DFDaniel S. Farrar
Daniel S. Farrar
LPLisa G. Pell
Lisa G. Pell
SAShabina Ariff
Shabina Ariff
SSSajid B. Soofi
Sajid B. Soofi
SMShaun K. Morris
Shaun K. Morris
During the perinatal period, women in low- and middle-income countries experience high rates of common mental disorders (CMDs). We aimed to estimate CMD prevalence at 6 and 12 months postpartum in Rahim Yar Khan (RYK), Pakistan, and identify factors associated with postpartum mental health. We conducted secondary analysis of a longitudinal birth cohort study, which was nested within the control arm of a community-based, cluster-randomized trial that enrolled pregnant women in their third trimester ( n = 2,122). Mental health was assessed using the Self-Reporting Questionnaire. Factors associated with postpartum mental health were explored using mixed-effects linear regression, and associations between preconception, antenatal and postpartum CMDs were assessed using robust Poisson regression. The prevalence of CMDs was 16% and 17% at 6 and 12 months postpartum, respectively. Women who reported that their husbands were unhappy had poorer postpartum mental health, whereas high social support was associated with improved postpartum mental health. History of antenatal CMDs was associated with increased risk of CMDs at 6 and 12 months postpartum (adjusted risk ratio = 2.60 and 1.90, 95% confidence interval: 1.69–4.01 and 1.40–2.58, respectively). Mothers with identified risk factors may benefit from targeted mental health support during the perinatal period.

10 June 2026 in Pediatric Pulmonology
Verified
Journal Article
Open access
ARAdria Rose
Adria Rose
RDRohini R. Datta
Rohini R. Datta
Costanza Di ChiaraCostanza Di Chiara
Costanza Di Chiara
PPPierre‐Philippe Piché‐Renaud
Pierre‐Philippe Piché‐Renaud
SMShaun K. Morris
Shaun K. Morris
Introduction: New RSV prevention products show strong potential, but their success depends on wide acceptance and use. We assessed Ontario pediatricians' knowledge and attitudes about these products before their introduction to highlight opportunities and barriers. Methods: In March−April 2024, Pediatricians Alliance of Ontario newsletter subscribers ( n = 1566) were invited to complete an online survey on RSV knowledge and attitudes. Descriptive analyses with a complete‐case approach assessed responses. Results: Of 117 responses (7% response rate), we retained 104 confirmed as from pediatricians with complete demographic data, including 81% (84/104) general pediatricians and 19% (20/104) subspecialists. Most worked in primary care (40%; 42/104), community hospitals (32%; 33/104), and urban centers (63%; 65/104), and had ≥ 10 years' experience (81%; 83/104). They had high awareness of provincial recommendations (91%; 94/103) and knowledge of severe RSV disease risk factors (Figure 2). While 83% (82/99) always recommended palivizumab to eligible patients, only 34% (34/99) reported that all eligible patients always received it. Over 90% were likely to recommend nirsevimab (91%; 89/98), but 66% (65/98) expected to administer it. Top anticipated barriers included the introduction of a new product (69%; 25/36) and concern for adverse effects (69%; 41/59). The likelihood of recommending a maternal vaccine over nirsevimab was 45% (44/98), while 44% (43/98) were neutral. Conclusion: Ontario pediatricians were knowledgeable and supportive of RSV prevention products. However, they have experienced barriers with palivizumab, and they anticipated barriers with nirsevimab and the maternal RSV vaccine. As other jurisdictions look to implement new RSV prevention products, acknowledging and addressing anticipated barriers may promote acceptance and use.

10 August 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
FIFederica Inturrisi
Federica Inturrisi
SYSafina Yuma
Safina Yuma
BMBariki Mchome
Bariki Mchome
AMAlex Mremi
Alex Mremi
PMPrisca Dominic Marandu
Prisca Dominic Marandu
KYKaren Yeates
Karen Yeates
Visual inspection of the cervix with acetic acid (VIA), although recognized as inaccurate, remains widely used for cervical screening in low-resource settings. Training and image review by more experienced providers − such as the smartphone-enhanced VIA (SEVIA) in Tanzania − are assumed to improve VIA performance, but remain untested against a reference standard of disease. Between June and December 2023, 486 VIA providers in Tanzania completed a questionnaire on experience- and training-related factors (years practicing VIA, patient volume, refresher training, SEVIA training) and independently reviewed a set of 50 high-quality cervical images (24,300 total reviews). Image reference diagnosis was defined using HPV status and histology: precancer if HPV-positive and histologically-confirmed CIN3, normal if HPV-negative and normal histology, otherwise indeterminate. For comparability, providers’ image reviews were recategorized into positive (VIA-positive for ablation, LEEP, or suspect cancer) or negative (VIA-negative). In an image-level analysis, we calculated proportion of providers labeling each image as positive and averaged those within subgroups of experience/training and reference diagnosis. Overall, providers (mean VIA experience 3.7 years, weekly VIA exams 12.2) showed moderate sensitivity: on average 60.0% (95% confidence interval 59.2 − 60.7) labeled precancers as positive and 54.4% (53.0 − 55.9) labeled normals as negative. More experienced providers tended to be more specific but less sensitive: for example, an average of 56.5% (55.2–57.9) of providers with ≥5 years of VIA experience labeled precancers as positive vs 61.4% (60.5–62.4) of providers with <5 years’ experience; corresponding proportions for images with normal diagnoses were 36.8% (34.3–39.4) vs 44.5% (42.7–46.3). In this image-based evaluation using a virologic/histologic reference diagnosis, VIA showed moderate sensitivity for detecting cervical precancer, and greater provider experience did not substantially increase overall accuracy. These findings challenge assumptions that experience alone improves VIA diagnostic performance, highlighting the need for objective quality assurance and more accurate screening methods.